Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing

After the development of EGFR tyrosine kinase inhibitors (TKIs), genetic testing of EGFR became required for effective treatment of lung cancer. Initially, the testing was conducted separately for each mutated region. However, many EGFR mutations have since been identified that determine the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Gou, Kikuchi, Mari, Kobayashi, Shiho, Arai, Yoshiko, Fujiyoshi, Kenji, Wakatsuki, Tomokazu, Kakuta, Miho, Yamane, Yuki, Iijima, Yoshihito, Mizutani, Hideaki, Nakajima, Yuki, Sudo, Junko, Kinoshita, Hiroyasu, Kurimoto, Futoshi, Akiyama, Hirohiko, Uramoto, Hidetaka, Sakai, Hiroshi, Akagi, Yoshito, Akagi, Kiwamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403533/
https://www.ncbi.nlm.nih.gov/pubmed/28350094
http://dx.doi.org/10.3892/ijo.2017.3935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403533/
https://www.ncbi.nlm.nih.gov/pubmed/28350094
http://dx.doi.org/10.3892/ijo.2017.3935

Ejemplares similares